Registry Study to Collect Data on Safety and Effectiveness of Treatments for Benign Prostatic Enlargement and Lower Urinary Tract Symptoms

What this Trial Is About

This research aims to collect data on the effectiveness and safety of various treatments for benign prostatic enlargement BPE and the lower urinary tract symptoms related to benign prostatic hyperplasia BPH-LUTS. The study includes men who receive treatment for these conditions at the participating institution and provides insights into different treatment options including newer methods compared to established surgical procedures. Participants receive one of several treatment options such as prostatic artery embolization PAE, transurethral resection of the prostate TURP, or other surgical procedures like holmium laser enucleation, open prostatectomy, and thulium laser vaporization. The study collects clinical, patient-reported, and imaging data prospectively as part of routine clinical care, enabling comparison of safety and efficacy among these treatment approaches. During the study, researchers will monitor participants over time, assessing changes in urinary symptoms, urinary flow rates, and residual urine volume from baseline up to one year and beyond. Assessments also include follow-up for adverse events, prostate size changes, erectile and ejaculatory function, and other outcomes over a period of up to five years. Participants contribute data through routine clinical visits, imaging, and questionnaires, helping to evaluate long-term treatment results and safety.

Database for the Assessment of Efficacy and Safety of BPH Treatment